Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GNMSF) Intangibles (2023 - 2025)

Historic Intangibles for Genmab A (GNMSF) over the last 3 years, with Q4 2025 value amounting to $9.1 billion.

  • Genmab A's Intangibles rose 42795.14% to $9.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $9.1 billion, marking a year-over-year increase of 42795.14%. This contributed to the annual value of $9.1 billion for FY2025, which is 42795.14% up from last year.
  • Genmab A's Intangibles amounted to $9.1 billion in Q4 2025, which was up 42795.14% from $1.8 billion recorded in Q1 2025.
  • Genmab A's 5-year Intangibles high stood at $9.1 billion for Q4 2025, and its period low was $15.0 million during Q4 2023.
  • Over the past 3 years, Genmab A's median Intangibles value was $1.7 billion (recorded in 2024), while the average stood at $3.2 billion.
  • Per our database at Business Quant, Genmab A's Intangibles soared by 1142000.0% in 2024 and then skyrocketed by 42795.14% in 2025.
  • Genmab A's Intangibles (Quarter) stood at $15.0 million in 2023, then soared by 11420.0% to $1.7 billion in 2024, then skyrocketed by 427.95% to $9.1 billion in 2025.
  • Its Intangibles stands at $9.1 billion for Q4 2025, versus $1.8 billion for Q1 2025 and $1.7 billion for Q4 2024.